166 related articles for article (PubMed ID: 1302008)
1. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
Bruening W; Bardeesy N; Silverman BL; Cohn RA; Machin GA; Aronson AJ; Housman D; Pelletier J
Nat Genet; 1992 May; 1(2):144-8. PubMed ID: 1302008
[TBL] [Abstract][Full Text] [Related]
2. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
[TBL] [Abstract][Full Text] [Related]
3. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
4. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
[TBL] [Abstract][Full Text] [Related]
5. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
6. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes).
Auber F; Lortat-Jacob S; Sarnacki S; Jaubert F; Salomon R; Thibaud E; Jeanpierre C; Nihoul-Fékété C
J Pediatr Surg; 2003 Jan; 38(1):124-9; discussion 124-9. PubMed ID: 12592634
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
[TBL] [Abstract][Full Text] [Related]
8. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
9. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
[TBL] [Abstract][Full Text] [Related]
10. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
[TBL] [Abstract][Full Text] [Related]
11. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.
Kohsaka T; Tagawa M; Takekoshi Y; Yanagisawa H; Tadokoro K; Yamada M
Hum Mutat; 1999; 14(6):466-70. PubMed ID: 10571943
[TBL] [Abstract][Full Text] [Related]
12. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
13. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
Hewitt SM; Saunders GF
Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
15. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
16. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function.
Guan LS; Liu JJ; Xu YH; Wang ZY
Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632
[TBL] [Abstract][Full Text] [Related]
17. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
Yang C; Romaniuk PJ
Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
[TBL] [Abstract][Full Text] [Related]
18. Inherited WT1 mutation in Denys-Drash syndrome.
Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis.
Rackley RR; Flenniken AM; Kuriyan NP; Kessler PM; Stoler MH; Williams BR
Cell Growth Differ; 1993 Dec; 4(12):1023-31. PubMed ID: 8117616
[TBL] [Abstract][Full Text] [Related]
20. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
